drugset / Trial / NCT07216131
A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to determine how the experimental medication AZD0780 impacts the pharmacokinetics (PK) of metformin, a common medication used to treat type 2 diabetes mellitus, when given together in healthy participants.
Timeline
- Start
- 2025-11-10
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Laroprovstat | Small molecule | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |
Indications
No indication recorded.